Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.

Luo C, Tetteh PW, Merz PR, Dickes E, Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek B, Schadendorf D, Diederichs S, Eichmüller SB.

J Invest Dermatol. 2013 Mar;133(3):768-75. doi: 10.1038/jid.2012.357. Epub 2012 Nov 15.

2.

MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.

Luo C, Merz PR, Chen Y, Dickes E, Pscherer A, Schadendorf D, Eichmüller SB.

Cancer Lett. 2013 Dec 1;341(2):240-7. doi: 10.1016/j.canlet.2013.08.021. Epub 2013 Aug 17.

PMID:
23962556
3.

Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.

Asangani IA, Harms PW, Dodson L, Pandhi M, Kunju LP, Maher CA, Fullen DR, Johnson TM, Giordano TJ, Palanisamy N, Chinnaiyan AM.

Oncotarget. 2012 Sep;3(9):1011-25.

4.

MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.

Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.

J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.

PMID:
24211739
5.

MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer.

Zhang H, Zhang H, Zhao M, Lv Z, Zhang X, Qin X, Wang H, Wang S, Su J, Lv X, Liu H, Du W, Zhou W, Chen X, Fei K.

Cell Physiol Biochem. 2013;31(1):56-65. doi: 10.1159/000343349. Epub 2013 Jan 15.

6.
7.

Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.

Yan D, Dong XD, Chen X, Yao S, Wang L, Wang J, Wang C, Hu DN, Qu J, Tu L.

PLoS One. 2012;7(7):e40967. doi: 10.1371/journal.pone.0040967. Epub 2012 Jul 27.

8.

Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.

Zhang Q, Padi SK, Tindall DJ, Guo B.

Cell Death Dis. 2014 Oct 23;5:e1486. doi: 10.1038/cddis.2014.454.

9.

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

Xia H, Ooi LL, Hui KM.

PLoS One. 2012;7(9):e44206. doi: 10.1371/journal.pone.0044206. Epub 2012 Sep 4. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/1be2a62e-45a1-4c13-9a8d-f265005a21e0.

10.

MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ.

J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35.

11.

Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.

Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J.

Oncotarget. 2015 Nov 10;6(35):37335-48. doi: 10.18632/oncotarget.6135.

12.

New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.

Margue C, Philippidou D, Reinsbach SE, Schmitt M, Behrmann I, Kreis S.

PLoS One. 2013 Sep 5;8(9):e73473. doi: 10.1371/journal.pone.0073473. eCollection 2013.

13.

miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.

Dynoodt P, Speeckaert R, De Wever O, Chevolet I, Brochez L, Lambert J, Van Gele M.

Int J Oncol. 2013 Apr;42(4):1443-51. doi: 10.3892/ijo.2013.1823. Epub 2013 Feb 12.

PMID:
23404256
14.

microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.

Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng ZL, He MM, Wang FH, Li YH, Zhang HZ, Pelicano H, Zhang W, Xu RH.

Oncotarget. 2015 May 10;6(13):10868-79.

15.

Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.

Eskander RN, Ji T, Huynh B, Wardeh R, Randall LM, Hoang B.

Int J Gynecol Cancer. 2013 Jul;23(6):997-1005. doi: 10.1097/IGC.0b013e318296a265.

16.

MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression.

Zhang K, Zhang Y, Ren K, Zhao G, Yan K, Ma B.

Oncol Rep. 2014 Nov;32(5):2143-9. doi: 10.3892/or.2014.3459. Epub 2014 Sep 2.

PMID:
25190211
17.

MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.

Dang X, Ma A, Yang L, Hu H, Zhu B, Shang D, Chen T, Luo Y.

Cancer Genet. 2012 Mar;205(3):113-23. doi: 10.1016/j.cancergen.2012.01.002.

PMID:
22469510
18.

MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.

Lin L, Zheng Y, Tu Y, Wang Z, Liu H, Lu X, Xu L, Yuan J.

Hum Pathol. 2015 Jul;46(7):971-80. doi: 10.1016/j.humpath.2015.01.023. Epub 2015 Mar 18.

PMID:
25907866
19.

MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.

Lei Q, Shen F, Wu J, Zhang W, Wang J, Zhang L.

Oncol Rep. 2014 Jul;32(1):261-9. doi: 10.3892/or.2014.3167. Epub 2014 May 7.

PMID:
24807198
20.

MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.

Zhang Y, Lin C, Liao G, Liu S, Ding J, Tang F, Wang Z, Liang X, Li B, Wei Y, Huang Q, Li X, Tang B.

Oncotarget. 2015 Oct 20;6(32):32586-601. doi: 10.18632/oncotarget.5309.

Supplemental Content

Support Center